Circumcision reduces risk of transmission of HIV by over 65 percent.  It is associated with reduced risk of HPV (32-35%), HSV-2 (25-34%), STIs, and prevention of genital cancers, including cervical and penile¹.  In 2016, WHO and UNAIDS targeted 27 million for Voluntary Medical Male Circumcision (VMMC) in 14 high priority countries.

ShangRing

ShangRing is a novel disposable circumcision device consisting of two concentric rings, inner and outer, and a silicon pad. The two rings lock together over the foreskin of the male reproductive organ and the silicon pad provides a good non bio-reactive surface. The ShangRing provides a low-cost, high quality, safe, non-invasive, low-pain and rapid method to provide VMMC services. ShangRing meets international safety standards and is FDA, WHO, EU-CE and ISO approved, for application on adolescent and adult males².

A WHO study (2013) found that ShangRing had no ‘serious’ adverse effects, and less than 1% ‘moderate’ adverse effects among 1,983 males³.

The Gates Foundation cited ShangRing as one of the innovative VMMC devices that is expected to have a significant impact in reducing the number of new HIV infections in Africa. The Bill and Melinda Gates Foundation have been supporting global programs, and Bill Gates was pictured at Stanford University⁴, mentioning that ShangRing “could greatly simplify the process of circumcising millions of men”.